Literature DB >> 7211516

Electroretinography (ERG) as a tool of investigation in human psychopharmacology. Electroretinographic changes induced by a combination of carbi-dopa and levo-dopa.

P Fornaro, P Castrogiovanni, M Perossini, G F Placidi, G Cavallacci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7211516

Source DB:  PubMed          Journal:  Acta Neurol (Napoli)        ISSN: 0001-6276


× No keyword cloud information.
  6 in total

1.  The effects of levodopa and haloperidol on flash and pattern ERGs and VEPs in normal humans.

Authors:  P Bartel; M Blom; E Robinson; C van der Meyden; D K Sommers; P Becker
Journal:  Doc Ophthalmol       Date:  1990-11       Impact factor: 2.379

2.  Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease.

Authors:  J Nguyen-Legros
Journal:  Surg Radiol Anat       Date:  1988       Impact factor: 1.246

3.  A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

Authors:  Michele Fornaro; Davide Prestia; Salvatore Colicchio; Giulio Perugi
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

Review 4.  Role of dopamine in distal retina.

Authors:  E Popova
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2014-04-12       Impact factor: 1.836

5.  Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis.

Authors:  Pantaleo Fornaro; Giovanni Calabria; Guido Corallo; Giovanni B Picotti
Journal:  Doc Ophthalmol       Date:  2002-07       Impact factor: 2.379

6.  Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

Authors:  Michele Fornaro; Fabio Bandini; Luca Cestari; Christian Cordano; Carla Ogliastro; Claudio Albano; Domenico De Berardis; Matteo Martino; Andrea Escelsior; Giulio Rocchi; Pantaleo Fornaro; Concetta De Pasquale
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-20       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.